Valuation: Kwality Pharmaceuticals Limited

Market Cap 3.83TCr 40Cr 36Cr 33Cr 30Cr 57Cr 57Cr 400.42Cr 159.03Cr 2.01TCr 151.28Cr 148.04Cr 6.36TCr P/E 2025
22.6x
P/E 2026 20.1x
Enterprise Value 3.96TCr 42Cr 37Cr 35Cr 31Cr 58Cr 59Cr 413.72Cr 164.31Cr 2.07TCr 156.3Cr 152.96Cr 6.57TCr EV / Sales 2025
2.7x
EV / Sales 2026 2.95x
Free-Float
22.51%
Yield 2025 *
-
Yield 2026 -
21/09 Kwality Pharmaceuticals Limited(BSE:539997) added to S&P Global BMI Index CI
02/09 Kwality Pharmaceuticals Limited Appoints Swanith Kapoor, as the Non-Executive Independent Director, Effective 02 June, 2026 CI
10/08 Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
02/06 Kwality Pharmaceuticals Limited Announces Resignation of Kartik Kapur as Independent Director, Effective June 02, 2026 CI
19/05 Kwality Pharmaceuticals' Consolidated Profit Rises in Fiscal Q4; Shares Jump 9% MT
19/05 Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 CI
19/05 Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
11/03 Chatha Foods Limited Announces Change in Designation of Mrs. Rachna Singh Chaudhary as Chief Human Resource Officer, Effective March 11, 2026 CI
10/03 Kwality Pharmaceuticals completes phase 1 BE studies for three molecules RE
12/02 Kwality Pharmaceuticals' Consolidated Profit Jumps in Fiscal Q3; Shares Surge 16% MT
12/02 Kwality Pharmaceuticals Ltd Dec-quarter consol net profit 160.1 million rupees RE
12/02 Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02/02 Kwality Pharmaceuticals Limited Announces Completion of Term of Pankaj Takkar and Ravi Shanker as Independent Directors and from Committees Membership and Chairmanship, Effective January 31, 2026 CI
1 day+2.30%
1 week+7.46%
Current month+1.46%
1 month+3.04%
3 months+42.48%
6 months+128.86%
Current year+232.86%
1 week 3,374.9
Extreme 3374.9
3,706
1 month 3,227
Extreme 3227
3,780.2
Current year 1,020
Extreme 1020
3,866.55
1 year 828.8
Extreme 828.8
3,866.55
3 years 320
Extreme 320
3,866.55
5 years 248
Extreme 248
3,866.55
10 years 21.3
Extreme 21.3
3,866.55
Manager TitleAgeSince
Chief Executive Officer 72 04/05/1983
Director of Finance/CFO 32 22/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 72 04/05/1983
Director/Board Member 58 01/08/1995
Director/Board Member 64 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
+2.30%+7.46%+306.26%+1,019.82% 39Cr
+1.18%+1.48%+57.25%+127.96% 1,14300Cr
+1.05%+4.52%+44.13%+83.25% 65TCr
+0.59%+0.83%+26.20%+102.39% 51TCr
+0.15%+1.84%+52.89%+65.44% 38TCr
+0.21%-5.51%+62.73%+37.92% 35TCr
+1.32%+2.47%+31.51%+53.63% 29TCr
+0.71%+1.92%+3.63%+25.82% 26TCr
+1.28%+3.06%+54.66%+71.65% 24TCr
+0.85%+4.20%+35.75%+105.76% 20TCr
Average +0.98%+1.51%+67.50%+169.36% 40.28TCr
Weighted average by Cap. +0.88%+0.71%+44.72%+87.27%

Financials

2025 2026
Net sales 370.2Cr 3.9Cr 3.5Cr 3.23Cr 2.93Cr 5.47Cr 5.54Cr 39Cr 15Cr 194.04Cr 15Cr 14Cr 615.34Cr 503.08Cr 5.3Cr 4.75Cr 4.39Cr 3.98Cr 7.44Cr 7.53Cr 53Cr 21Cr 263.7Cr 20Cr 19Cr 836.22Cr
Net income 40Cr 41.95L 37.65L 34.76L 31.52L 58.92L 59.64L 4.17Cr 1.66Cr 21Cr 1.57Cr 1.54Cr 66Cr 67Cr 70.9L 63.63L 58.76L 53.28L 99.58L 1.01Cr 7.04Cr 2.8Cr 35Cr 2.66Cr 2.6Cr 111.94Cr
Net Debt 98Cr 1.03Cr 92.31L 85.23L 77.29L 1.44Cr 1.46Cr 10Cr 4.06Cr 51Cr 3.86Cr 3.78Cr 162.38Cr 127.11Cr 1.34Cr 1.2Cr 1.11Cr 1.01Cr 1.88Cr 1.9Cr 13Cr 5.28Cr 67Cr 5.02Cr 4.92Cr 211.29Cr
Projected Income Statement - Annual - Kwality Pharmaceuticals Limited
Logo Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
Employees
1,137
Date Price Change Volume
28/26/28 ₹3,689.25 +2.30% 4,812
27/26/27 ₹3,606.40 +4.41% 1,856
26/26/26 ₹3,453.95 -2.20% 7,387
23/26/23 ₹3,531.70 -2.48% 11,121
22/26/22 ₹3,621.45 +5.49% 8,838

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Kwality Pharmaceuticals Limited